U.S. market Open. Closes in 5 hours 4 minutes

KRYS | Krystal Biotech, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 176.14 - 181.95
52 Week Range 141.72 - 219.34
Beta 0.75
Implied Volatility 46.99%
IV Rank 42.41%
Day's Volume 291,813
Average Volume 264,111
Shares Outstanding 28,806,100
Market Cap 5,193,739,830
Sector Healthcare
Industry Biotechnology
IPO Date 2017-09-20
Valuation
Profitability
Growth
Health
P/E Ratio 60.10
Forward P/E Ratio N/A
EPS 3.00
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 229
Country USA
Website KRYS
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
*Chart delayed
Analyzing fundamentals for KRYS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is very poor, Growth is very bad and Health is very strong. For more detailed analysis please see KRYS Fundamentals page.

Watching at KRYS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on KRYS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙